Prostate Cancer Market 2025 to 2035
Prostate Cancer Market 2025 to 2035
Prostate Cancer Market (By Drug Class: Hormonal ADT, AR-Directed Therapies, Cytotoxic Agents, Bone Metastases, Therapeutic Vaccines, PARP Inhibitors, Kinase Inhibitors, PSMA-Targeted Radioligands; By Distribution Channel: Hospital Pharmacies, Drug Store & Retail Pharmacies, Online Pharmacies; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2035.
Customisation Request
Revenue, 2025
USD 12.88 Bn
Forecast Year, 2035
USD 28.83 Bn
CAGR, 2025 - 2035
8.50%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global prostate cancer market, valued at USD 12.88 billion in 2025, is projected to reach USD 28.83 billion by 2035, growing at a CAGR of 8.5%, driven by rising prevalence, advanced diagnostics, and innovative treatment options.
Prostate Cancer Market Size Analysis
Prostate Cancer Market Size By Drug Class 2025 to 2035 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hormonal ADT | 0.76 | 0.79 | 0.82 | 0.90 | 0.94 | 1.00 | 1.10 | 1.22 | 1.30 | 1.43 | 1.48 |
| AR-Directed Therapies | 1.09 | 1.23 | 1.38 | 1.44 | 1.55 | 1.67 | 1.76 | 2.00 | 2.25 | 2.35 | 2.52 |
| Cytotoxic agents | 1.18 | 1.32 | 1.39 | 1.51 | 1.60 | 1.78 | 1.93 | 2.12 | 2.25 | 2.50 | 2.72 |
| Bone metastases | 1.27 | 1.35 | 1.41 | 1.54 | 1.64 | 1.78 | 1.98 | 2.25 | 2.49 | 2.64 | 2.82 |
| therapeutic vaccines | 1.72 | 1.81 | 1.87 | 1.97 | 2.17 | 2.46 | 2.74 | 2.99 | 3.12 | 3.28 | 3.70 |
| PARP inhibitors | 1.85 | 2.05 | 2.20 | 2.42 | 2.54 | 2.70 | 2.92 | 3.07 | 3.39 | 3.79 | 3.98 |
| Kinase inhibitors | 2.02 | 2.17 | 2.44 | 2.74 | 3.08 | 3.35 | 3.69 | 3.83 | 3.99 | 4.43 | 4.86 |
| PSMA-targeted radioligands | 2.98 | 3.25 | 3.66 | 3.94 | 4.33 | 4.63 | 4.88 | 5.33 | 5.94 | 6.43 | 7.02 |
Prostate Cancer Market Size By Distribution Channel 2025 to 2035 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 2.02 | 2.26 | 2.50 | 2.80 | 3.09 | 3.19 | 3.57 | 4.01 | 4.34 | 4.57 | 4.99 |
| Drug store & Retail pharmacies | 5.04 | 5.41 | 5.76 | 6.20 | 6.81 | 7.60 | 8.18 | 8.76 | 9.38 | 10.15 | 11.05 |
| Online pharmacies | 5.81 | 6.30 | 6.89 | 7.45 | 7.95 | 8.58 | 9.27 | 10.03 | 11.01 | 12.12 | 13.07 |
Prostate Cancer Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.63 | 1.81 | 2.01 | 2.18 | 2.28 | 2.52 | 2.79 | 2.99 | 3.17 | 3.51 | 3.85 |
| Europe | 2.26 | 2.41 | 2.60 | 2.73 | 2.91 | 3.20 | 3.48 | 3.73 | 3.95 | 4.19 | 4.58 |
| Asia Pacific | 2.59 | 2.70 | 3.00 | 3.20 | 3.54 | 3.94 | 4.16 | 4.52 | 5.08 | 5.45 | 5.76 |
| Latin America | 2.87 | 3.12 | 3.27 | 3.64 | 3.84 | 4.16 | 4.64 | 5.08 | 5.55 | 5.96 | 6.51 |
| Middle East and Africa | 3.53 | 3.93 | 4.29 | 4.70 | 5.28 | 5.55 | 5.94 | 6.48 | 6.99 | 7.73 | 8.43 |
Prostate Cancer Market Size to Touch USD 28.83 Billion by 2035
The global prostate cancer market size was calculated at USD 12.88 billion in 2025 and is predicted to attain around USD 28.83 billion by 2035 a CAGR of 8.50%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
